前言： 目的：研究巴曲酶联合阿斯匹林治疗短暂性脑缺血发作（T IA）的有效性和安全性。
Objective: To study the curative effect and safe of batroxobin injection with aspirin to treat TIA.
SPARCL研究由全世界范围内205个医学中心治疗卒中或轻微卒中（过去称短暂性脑缺血发作TIA）的4700名受试病人组成。
SPARCL involved more than 4,700 individuals treated for strokes or "mini-strokes" (formally called transient ischemic attacks) at 205 medical centers around the world.
SPARCL研究由全世界范围内205个医学中心治疗卒中或轻微卒中（过去称短暂性脑缺血发作TIA）的4700名受试病人组成。
SPARCL involved more than 4,700 individuals treated for strokes or "mini-strokes" (formally called transient ischemic attacks) at 205 medical centers around the world.
应用推荐